246 related articles for article (PubMed ID: 31406460)
1. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
2. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
4. A facile approach for fabricating CD44-targeted delivery of hyaluronic acid-functionalized PCL nanoparticles in urethane-induced lung cancer: Bcl-2, MMP-9, caspase-9, and BAX as potential markers.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Saraf SA
Drug Deliv Transl Res; 2019 Feb; 9(1):37-52. PubMed ID: 30178279
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
Wang T; Hou J; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
[TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.
Ganesh S; Iyer AK; Gattacceca F; Morrissey DV; Amiji MM
J Control Release; 2013 Dec; 172(3):699-706. PubMed ID: 24161254
[TBL] [Abstract][Full Text] [Related]
7. Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticles.
Nascimento AV; Singh A; Bousbaa H; Ferreira D; Sarmento B; Amiji MM
Acta Biomater; 2017 Jan; 47():71-80. PubMed ID: 27697601
[TBL] [Abstract][Full Text] [Related]
8. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
9. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
10. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
Almutairi FM; Abd-Rabou AA; Mohamed MS
Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
[TBL] [Abstract][Full Text] [Related]
11. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression.
Izadi S; Moslehi A; Kheiry H; Karoon Kiani F; Ahmadi A; Masjedi A; Ghani S; Rafiee B; Karpisheh V; Hajizadeh F; Atyabi F; Assali A; Mirzazadeh Tekie FS; Namdar A; Ghalamfarsa G; Sojoodi M; Jadidi-Niaragh F
Pharm Res; 2020 Sep; 37(10):196. PubMed ID: 32944844
[TBL] [Abstract][Full Text] [Related]
12. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression.
Masjedi A; Ahmadi A; Atyabi F; Farhadi S; Irandoust M; Khazaei-Poul Y; Ghasemi Chaleshtari M; Edalati Fathabad M; Baghaei M; Haghnavaz N; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Sabz G; Hasanzadeh S; Jadidi-Niaragh F
Int J Biol Macromol; 2020 Apr; 149():487-500. PubMed ID: 32004600
[TBL] [Abstract][Full Text] [Related]
13. Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted
Shahidi M; Abazari O; Dayati P; Reza JZ; Modarressi MH; Tofighi D; Haghiralsadat BF; Oroojalian F
Nanomedicine (Lond); 2023 Feb; 18(3):259-277. PubMed ID: 37125618
[TBL] [Abstract][Full Text] [Related]
14. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
[TBL] [Abstract][Full Text] [Related]
15. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice.
Bastaki S; Aravindhan S; Ahmadpour Saheb N; Afsari Kashani M; Evgenievich Dorofeev A; Karoon Kiani F; Jahandideh H; Beigi Dargani F; Aksoun M; Nikkhoo A; Masjedi A; Mahmoodpoor A; Ahmadi M; Dolati S; Namvar Aghdash S; Jadidi-Niaragh F
Life Sci; 2021 Feb; 266():118847. PubMed ID: 33309720
[TBL] [Abstract][Full Text] [Related]
16. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
[TBL] [Abstract][Full Text] [Related]
17. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
18. Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
Veilleux D; Gopalakrishna Panicker RK; Chevrier A; Biniecki K; Lavertu M; Buschmann MD
J Colloid Interface Sci; 2018 Feb; 512():335-345. PubMed ID: 29080529
[TBL] [Abstract][Full Text] [Related]
19. Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.
Contreras-Ruiz L; de la Fuente M; Párraga JE; López-García A; Fernández I; Seijo B; Sánchez A; Calonge M; Diebold Y
Mol Vis; 2011 Jan; 17():279-90. PubMed ID: 21283563
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronan-based nanocarriers with CD44-overexpressed cancer cell targeting.
Song S; Qi H; Xu J; Guo P; Chen F; Li F; Yang X; Sheng N; Wu Y; Pan W
Pharm Res; 2014 Nov; 31(11):2988-3005. PubMed ID: 24842660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]